Valmet supplies a Valmet IntelliTissue 1600 tissue making line to Chinese tissue producer C&S. The new line will be installed at the company’s mill in Tangshan, China. The start-up is scheduled for the first quarter of 2022.
The order was included in Valmet’s orders received of the first quarter 2021. The value of the order will not be disclosed. However, a project of this size and scope is typically valued at around EUR 5-10 million.
Valmet IntelliTissue machines belong to the small and medium size tissue machines that were integrated to Valmet’s offering when the company acquired PMP from Poland in 2020. Thanks to a long-term customer relationship, this order will be Valmet’s twelfth IntelliTissue tissue making line delivery to C&S.
“The target for our investment is to expand C&S’ share on the Chinese tissue market. We have decided to go for the IntelliTissue technology and execute the project together with Valmet due to their excellent references implemented worldwide,” says Tiande Lin, Director of Technology Center, C&S.
“This solution is a perfect match to the customers’ expectations. Valmet’s IntelliTissue technology ensures low energy consumption and high tissue quality thanks to state-of-the-art technology. The machines are responding to the needs of the customers in developing markets who see the possibility to grow their business not only by increasing the capacity, but also by lowering the production costs,” says Harrison Zhang, Vice General Manager of SMM (Small and medium size machinery), Changzhou, Paper business line, Valmet.
RELATED NEWS
